ESMO25: Acceleration, accessibility, and accuracy, with Barry Vucsko

Oncology

Interview at ESMO 2025 with EVERSANA's Barry Vucsko

At ESMO 2025, pharmaphorum caught up with Barry Vucsko, Senior Vice President of Strategic Development, Agency Services, for the EVERSANA Oncology Centre of Excellence, to discuss his takeaways from the Congress on AI in oncology.

Vucsko discusses EVERSANA OCE’s commercialisation and AI reputation, as well as AI-based image biomarkers, the technology’s role in remote patient monitoring and digital health, and full digitalisation of labs. He also comments on the new ELCAP guidance and the potential role of ChatGPT in cancer care.

Watch this and other conversations from ESMO 2025 here.

Nicole Raleigh

27 October, 2025

ESMO 2025

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.